Jupiter Life Line Hospitals Limited vs Laurus Labs Limited

A side-by-side comparison of Jupiter Life Line Hospitals Limited (JLHL) and Laurus Labs Limited (LAURUSLABS) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

Jupiter Life Line Hospitals Limited vs Laurus Labs Limited are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.

  • Valuation31
  • Profitability13
  • Growth20
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

JLHL takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

41.78
P/E ratio
125.08
5.96
P/B ratio
19.74
0.36%
Dividend yield
0.10%
₹5.92
EPS
₹16.47

Profitability

LAURUSLABS takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

12.59%
Return on equity
16.77%
14.00%
Return on capital
17.58%
22.89%
EBITDA margin
26.09%
13.27%
Net margin
13.07%

Growth

JLHL takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

18.87%
Revenue CAGR (3Y)
4.09%
39.71%
Profit CAGR (3Y)
3.91%

Size & financial health

LAURUSLABS takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹8,102 Cr
Market cap
₹1.11L Cr
₹1,500 Cr
Revenue
₹6,813 Cr
₹199 Cr
Net profit
₹890 Cr
0.38
Debt / equity
0.45
Jupiter Life Line Hospitals Limited
  • + ["Company has delivered good sales growth of 25.3% CAGR over last 5 years"]
  • − ["Stock is trading at 5.25 times its book value"]
Laurus Labs Limited
  • + []
  • − ["Stock is trading at 21.00 times its book value", "The company has delivered a poor sales growth of 7.2% over past five years.", "The company has delivered a poor profit growth of -2.0% over past five years."]
Jupiter Life Line Hospitals Limited full analysis Laurus Labs Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.